UChicago students, faculty, staff and alums can apply for the chance to win $10,000 to build an app. Submit your good idea, and UChicago, in partnership with IT Services and the Polsky Center, will do the programming to build it–no tech skills required to apply!
Join the ranks of ITM investigators, like Daniel Rubin, who are developing world-changing apps with the help of the App Challenge’s funding and programming support.
The National Cancer Institute will award $400,000 per year for up to five years for projects that develop state-of-the-art biomimetic tissue-engineered technologies for cancer research. Collaborative, multidisciplinary projects that engage the fields of regenerative medicine, tissue engineering, biomaterials, and bioengineering with cancer biology will be essential for generating novel experimental models that mimic cancer pathophysiology. The projects supported by this FOA will establish and collectively participate in the Cancer Tissue Engineering Collaborative (TEC) Research Program.
NIH’s, the ITM’s parent organization, National Institute on Aging and National Cancer Institute will fund research projects that increase our understanding of the clinical translational potential of metformin to delay aging changes or to extend healthy human life span. This includes identification of specific populations particularly likely to benefit from treatment, and/or obtaining information on metformin’s effects that would be useful in identifying novel molecular targets.
The NIH’s National Institute on Aging will award $40,000 per year to applications from qualified researchers to acquire training and career development experiences that close expertise gaps in data science and in drug discovery. The goal of the program is to allow Alzheimer’s Disease (AD) researchers to expand their expertise to become more effective in leading cross-disciplinary, translational, team-science projects in AD research.
Source: National Institute on Aging
ITM’s partner the Center for Health and the Social Sciences (CHeSS) and NORC’s Aging Action Research Network (AARN) are pleased to announce a call for applications for a predoctoral fellowship program in the social sciences at the UChicago.
Funded by the George E. Richmond Foundation, this fellowship promotes the scholarship of doctoral (PhD) students in the social sciences or a related field at the UChicago who have decided to make oral health a focus of their doctoral dissertations. CHeSS is currently accepting applications for predoctoral fellows.
Upon being awarded the fellowship, the accepted fellow will work with program directors and administrators to determine a budget for the fellowship period. There are no citizenship requirements for this award.
ITM’s partner the Center for Health and the Social Sciences (CHeSS) and NORC’s Aging Action Research Network (AARN) are pleased to announce a call for applications for a predoctoral fellowship programs in the social sciences at the UChicago.
Funded by the National Institute on Aging (NIA), this program trains doctoral recipients and students interested in the demography and economics of aging through the development of basic and applied research and policy-making and analysis. CHeSS is currently accepting applications for predoctoral fellows and student affiliates.
Predoctoral Fellowships – Fellowships include funding for stipend, tuition, and training related expenses and are available for one year with the option to renew for a second year. Most fellows accepted to the program are beginning their fourth year or later of PhD training; applicants must be U.S. citizens or permanent residents.
Predoctoral Student Affiliates – Affiliate positions are unfunded and are open to students who do not meet the citizenship requirements for predoctoral fellowships and/or are in the first 1-3 years of graduate training.
Translating biomedical discoveries into real-world applications is essential to improving human health. It’s a complex process that can result in delays of years or decades before improved patient outcomes result from discoveries in biomedical research – and NCATS wants solutions. NCATS’ (the ITM’s parent organization) spurs the development, demonstration, and dissemination of innovations across the translational science spectrum to turn discoveries from the laboratory into tangible benefits to human health. NCATS’s Clinical and Translational Science Award (CTSA) hubs, like the ITM, promote advances in translational research and training at participating institutions.
This funding opportunity funds up to $275,000 to new exploratory and developmental research projects. These studies may involve considerable risk but may lead to a breakthrough in a particular area, or to the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on translational science. This grant will enable collaborative teams of investigators from at least two different CTSA institutions to address translational science questions. Collaborations that bring together approaches from different scientific disciplines are encouraged.
NCATS will fund up to $500,000 per year for projects that support testing new therapeutic uses for experimental drugs across a broad range of pediatric diseases. This innovative program allows investigators to propose new therapeutic uses for drugs from pharmaceutical company partners. Strong applications will include scientific evidence that your drug repurposing will have a positive impact on the disease/condition.
Source: NIH NCATS
The NIH’s National Cancer Institute (the NIH is the parent organization of the ITM) will fund $4 million to approximately 10 exploratory projects that develop or validate emerging technologies that contribute to targeting, probing, or assessing molecular and cellular features of cancer biology. Projects should show potential to improve cancer biology research, early detection and screening, clinical diagnosis, treatment, control, epidemiology, and/or address issues associated with cancer health disparities.
Source: National Cancer Institute
The NIH’s National Cancer Institute (the NIH is the parent organization of the ITM) will fund $4 million to approximately 10 exploratory projects focused on the inception and early-stage development of innovative molecular and cellular analysis technologies. Projects should show potential to improve cancer biology research, early detection and screening, clinical diagnosis, treatment, control, epidemiology, and/or address issues associated with cancer health disparities.
Source: National Cancer Institute